Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) reported upbeat second-quarter earnings and 2025 guidance on Thursday. The company ...

CyberArk Software Ltd. (NASDAQ:CYBR) is one of the 10 AI Stocks Investors Should Keep an Eye On. On July 30, William Blair ...

Lenz Therapeutics has earned the FDA’s go-ahead for its aceclidine eye drop to crack the large presbyopia market, where past ...

In CCC v AAC [2025] HKCFI 2987, Sir William Blair, sitting as Deputy High Court Judge in the Hong Kong Court of First Instance (“Court”), rejected ...

Despite the overall decline in commercial product revenue, Moderna was also pleasantly surprised by Q2 Spikevax sales, which ...

We continue to feel confident about our ability to capture 90%," LPL CEO Rich Steinmeier told analysts during the firm's 2nd ...

Enovix's Q2 2025 earnings call highlights record revenue growth, A1 platform launch, and commercialization strides.

Global stocks weakened on Friday morning after US President Donald Trump hit multiple countries with a blitz of tariffs.

IBS Intelligence (IBSi) is the world’s only pure-play Financial Technology focused research, advisory, and fintech news ...

Discover how Casella Waste Systems achieved record Q2 2025 results with robust acquisitions, strong cash flow, and elevated guidance—despite ...

Detailed price information for Oxford Square Capital Corp 6.25% Notes Due 2026 (OXSQZ-Q) from The Globe and Mail including charting and trades.

Eli Lilly’s trial evaluating Mounjaro in reducing cardiovascular risk met its endpoint, though missed analyst expectations.